top of page
Nelson Advisors > European Healthcare Technology Investment Banking


Nelson Advisors: OpenEvidence's Capital Architecture, Clinical Decision Infrastructure and Strategic Outlook Toward 2027
OpenEvidence has established itself as the preeminent artificial intelligence platform in United States clinical practice, commonly referred to across the digital health ecosystem as the "ChatGPT for Doctors". Conceived by serial technologist Daniel Nadler and machine learning researcher Zachary Ziegler, the platform was developed to address an acute structural crisis in modern medicine: the velocity of peer-reviewed biomedical literature, which currently doubles every 73 day
Nelson Advisors
1 hour ago


The Phoenix Partnership (TPP) and SystmOne: Valuation Assessment and Strategic Transaction Analysis
The Phoenix Partnership (Leeds) Ltd (TPP) represents one of the most profitable and entrenched software platforms within the United Kingdom's digital health infrastructure. Operating its proprietary electronic health record (EHR) platform, SystmOne, TPP maintains an entrenched duopoly alongside EMIS Health, together administering the clinical data and consultation workflows of more than 90% of general practices across England. In the financial year ending 31st March 2025, TPP
Nelson Advisors
7 days ago


Nelson Advisors: Boutique Investment Banking in European Healthcare Technology M&A
Nelson Advisors LLP is a London headquartered investment banking and corporate finance advisory boutique established in 2023 that operates exclusively within the European Healthcare Technology (HealthTech), Medical Technology (MedTech), and Healthcare Artificial Intelligence (Healthcare AI) sectors. Headquartered at Hale House, 76–78 Portland Place in Marylebone, London, the firm advises clients within the lower to middle market, concentrating on transactions with enterprise
Nelson Advisors
Sep 5


Geographic Arbitrage in European HealthTech: Why the Next Platform Deal Might Be in the Nordics, DACH or the Netherlands, Not London
This financial environment has laid the groundwork for geographic arbitrage across European mid-market private equity. While London historically commanded a disproportionate share of early-stage venture funding, institutional investors seeking scalable buy-and-build platform deals are increasingly looking to the DACH region (Germany, Austria, Switzerland), the Nordic countries and the Netherlands.
Nelson Advisors
Jul 31


2026 European HealthTech M&A Outlook: Key Emerging Themes and Market Forces, Liquidity Pressures and the Artificial Intelligence Deflationary Wave
The European healthcare technology and medical technology sectors have reached a definitive operational and financial inflection point. Following a period of post-pandemic recalibration, the transaction landscape has transitioned into an era of disciplined industrial maturity, widely characterised by market analysts as the "Great Rationalisation". The speculative business models of the early 2020s, which prioritised user acquisition and un-monetised top-line expansion, have b
Nelson Advisors
Jun 15
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
bottom of page